SECOND SIGHT MED PRODS INC's ticker is EYESXXXX and the CUSIP is 81362J100. A total of 52 filers reported holding SECOND SIGHT MED PRODS INC in Q3 2015. The put-call ratio across all filers is 1.51 and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2019 | $13,000 | -7.1% | 15,746 | -8.6% | 0.00% | – |
Q2 2019 | $14,000 | -33.3% | 17,222 | -33.6% | 0.00% | – |
Q1 2019 | $21,000 | +10.5% | 25,938 | +20.8% | 0.00% | – |
Q4 2018 | $19,000 | -68.9% | 21,464 | -33.7% | 0.00% | – |
Q3 2018 | $61,000 | +22.0% | 32,357 | +7.4% | 0.00% | – |
Q2 2018 | $50,000 | -13.8% | 30,133 | -0.8% | 0.00% | – |
Q1 2018 | $58,000 | -12.1% | 30,375 | -12.1% | 0.00% | – |
Q4 2017 | $66,000 | +112.9% | 34,546 | +31.9% | 0.00% | – |
Q3 2017 | $31,000 | -65.6% | 26,200 | -63.2% | 0.00% | – |
Q2 2017 | $90,000 | +462.5% | 71,193 | +442.5% | 0.00% | – |
Q1 2017 | $16,000 | -96.3% | 13,123 | -89.3% | 0.00% | – |
Q2 2016 | $437,000 | +18.4% | 122,095 | +59.7% | 0.00% | – |
Q1 2016 | $369,000 | +25.1% | 76,451 | +52.4% | 0.00% | – |
Q4 2015 | $295,000 | -52.1% | 50,162 | -51.7% | 0.00% | – |
Q3 2015 | $616,000 | +28.6% | 103,876 | +194.7% | 0.00% | – |
Q2 2015 | $479,000 | +1.1% | 35,244 | -4.8% | 0.00% | – |
Q1 2015 | $474,000 | -9.2% | 37,007 | -27.3% | 0.00% | – |
Q4 2014 | $522,000 | – | 50,890 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Versant Venture Management, LLC | 4,492,975 | $8,536,653,000 | 2.90% |
Glassman Wealth Services | 72,366 | $137,000 | 0.06% |
B. Riley Wealth Management, Inc. | 53,500 | $102,000 | 0.02% |
Sigma Planning Corp | 223,400 | $424,000 | 0.02% |
Fore Capital, LLC | 40,000 | $76,000 | 0.02% |
Psagot Value Holdings Ltd. | 218,555 | $415,000 | 0.02% |
HBK Sorce Advisory LLC | 85,500 | $162,000 | 0.02% |
WealthTrust Axiom LLC | 10,000 | $19,000 | 0.01% |
INSTITUTIONAL & FAMILY ASSET MANAGEMENT, LLC | 12,894 | $24,000 | 0.01% |
Weiss Asset Management LP | 29,691 | $56,000 | 0.00% |